Disease/Infection News

RSS

Large-scale study focuses on COVID-19 antibodies in asymptomatic and symptomatic patients

MUSC Hollings Cancer Center researchers added to the understanding of the protective immune response against the SARS-CoV-2 virus in a study published in April in iScience.

6 May 2021

COVID-19 vaccination dramatically reduces symptomatic and asymptomatic infections

Vaccination dramatically reduced COVID-19 symptomatic and asymptomatic infections in St. Jude Children's Research Hospital employees compared with their unvaccinated peers, according to a research letter that appears today in the Journal of the American Medical Association.

6 May 2021

India's successful program to eliminate polio provides guidance for mass immunization initiatives

As India urgently scales up its vaccination campaign for the COVID-19 virus, a new study which examined the country's successful program to eliminate polio provides guidance on how this and future mass immunization campaigns can be successful, especially in vaccinating hard to reach groups.

6 May 2021

Survey finds only 41% of people were interested in participating in the COVID-19 vaccine trials

Research conducted by the University of Birmingham shows in order to have an effective COVID-19 vaccination rollout it has to be widely accepted by the entire population.

6 May 2021

Study investigates 12-month respiratory outcomes in patients hospitalized for COVID-19

A new study has shown that most patients discharged from hospital after experiencing severe COVID-19 infection appear to return to full health, although up to a third do still have evidence of effects upon the lungs one year on.

6 May 2021

Study: Novavax Covid-19 vaccine is efficacious against the B.1.351 South African variant

The published data provide additional detail of an initial analysis conducted in January, while more robust data from a complete analysis of the study was subsequently shared in March 2021.

6 May 2021

Unemployed Australian citizens experience mental health deterioration during COVID-19 pandemic, finds study

A team of scientists in Australia has recently investigated the health condition of Australian citizens who lost jobs during the coronavirus disease 2019 (COVID-19) pandemic. The study findings reveal that job loss is associated with a deterioration in mental health but an improvement in physical health. Importantly, retaining employment has shown a positive impact on the overall mental health condition.

6 May 2021

SARS-CoV-2 is activated for fusion by a broad range of proteases, finds study

A team of researchers from the University of Virginia, USA, used single-virus fusion experiments with exogenously controlled proteases to investigate the mechanism of activation directly. They found that the subcellular location of entry depends on the protease activity of the various components, and parallel pathways are possible.

6 May 2021

Transplant recipients with COVID-19 may show lower cellular and antibody immune responses

Transplant patients are typically on chronic immunosuppression, making them automatically more vulnerable to infection with SARS-CoV-2, the agent responsible for the loss of over three million lives in the current COVID-19 pandemic. A new study discusses evidence for subnormal immune responses following COVID-19 in this population.

6 May 2021

Aberrant immune features in healthy elderly and male subjects with severe COVID-19 may predate infection

A new study shows that the immunological features of severe COVID-19 are already present in healthy older adults and in men, before they are infected, indicating a possible explanation for this differential susceptibility towards the virus.

6 May 2021

Could stem cells improve the outcome of ARDS in severe COVID-19?

A recent study, published in Stem Cells Translational Medicine, explores the safety and efficacy of stem cells, which have been touted as the panacea for a wide range of illnesses, ranging from chronic degenerative conditions to cancer.

6 May 2021

About 84% of antibodies in plasma target non-RBD epitopes on SARS-CoV-2 spike protein, finds study

In a new study recently published in the journal Science, a team of researchers in the U.S. found that most of the antibodies circulating in the blood target areas of the viral spike protein outside the receptor-binding domain (RBD), the part of the spike that binds directly to human cell receptors.

6 May 2021

Researchers develop a multivalent vaccine for COVID-19 and influenza

Researchers at Duke University, USA, are looking into the possibility of a combined influenza and COVID-19 vaccine that could be used to simultaneously protect against annual flu strains and the SARS-CoV-2. Preclinical results showed the vaccine protected mice from both SARS-CoV-2 and the flu.

6 May 2021

Research shows how the world’s population has created an ideal breeding ground for infectious diseases

The way that many of us live has created the “perfect storm” for the evolution and transmission of infectious diseases like Covid-19 according to a researcher at the University of East Anglia.

6 May 2021

People with Covid-19 anxiety syndrome may find it harder to return to normal living after pandemic

‘Covid-19 anxiety syndrome’ may cause a significant number of people to struggle with reintegrating back into daily life as UK society returns to normal after the pandemic, says new research by London South Bank University (LSBU), in partnership with Kingston University.

6 May 2021

Study: Millions of COVID-19 cases can be prevented by reaching higher vaccination coverage levels

With around 30 percent of the U.S. population now fully vaccinated, the rate of daily vaccinations has started to slow, raising concerns that greater efforts and investments may be needed to reach higher coverage levels.

6 May 2021

Study examines artemisinin-based combination therapy as first-line treatment for malaria

When a mosquito begins to nibble on you, it is not merely feeding on your blood, it is also injecting its saliva into your skin. If that saliva happens to be full of parasites carrying malaria or other diseases from its last victim, then most likely you will become infected, too.

6 May 2021

WHO hails Sweden’s announcement to share 1 million doses of AstraZeneca vaccine with COVAX

WHO Dr Tedros Adhanom Ghebreyesus welcomed the Government of Sweden's announcement today to share 1 million doses of the AstraZeneca vaccine with the COVAX Facility to provide life-saving vaccines to people at risk from COVID-19 in low income countries.

6 May 2021

WHO and Federal Republic of Germany establish new global hub for pandemic and epidemic intelligence

The World Health Organization (WHO) and the Federal Republic of Germany will establish a new global hub for pandemic and epidemic intelligence, data, surveillance and analytics innovation.

6 May 2021

Study finds no evidence of increased risk for COVID-19 from aspirin/NSAID use

At the beginning of the pandemic, there were concerns over the use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs), increasing the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. NSAIDs are commonly used to treat SARS-CoV-2 infection-related symptoms such as flu and cough and are frequently taken by older adults with multiple health conditions.

6 May 2021

Disease/Infection News

Large-scale study focuses on COVID-19 antibodies in asymptomatic and symptomatic patients

COVID-19 vaccination dramatically reduces symptomatic and asymptomatic infections

India's successful program to eliminate polio provides guidance for mass immunization initiatives

Survey finds only 41% of people were interested in participating in the COVID-19 vaccine trials

Study investigates 12-month respiratory outcomes in patients hospitalized for COVID-19

Study: Novavax Covid-19 vaccine is efficacious against the B.1.351 South African variant

Unemployed Australian citizens experience mental health deterioration during COVID-19 pandemic, finds study

SARS-CoV-2 is activated for fusion by a broad range of proteases, finds study

Transplant recipients with COVID-19 may show lower cellular and antibody immune responses

Aberrant immune features in healthy elderly and male subjects with severe COVID-19 may predate infection

Could stem cells improve the outcome of ARDS in severe COVID-19?

About 84% of antibodies in plasma target non-RBD epitopes on SARS-CoV-2 spike protein, finds study

Researchers develop a multivalent vaccine for COVID-19 and influenza

Research shows how the world’s population has created an ideal breeding ground for infectious diseases

People with Covid-19 anxiety syndrome may find it harder to return to normal living after pandemic

Study: Millions of COVID-19 cases can be prevented by reaching higher vaccination coverage levels

Study examines artemisinin-based combination therapy as first-line treatment for malaria

WHO hails Sweden’s announcement to share 1 million doses of AstraZeneca vaccine with COVAX

WHO and Federal Republic of Germany establish new global hub for pandemic and epidemic intelligence

Study finds no evidence of increased risk for COVID-19 from aspirin/NSAID use

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Automating research - solutions and best practices

Latest News